Ipsen SA (France) Today
| IPN Stock | EUR 111.30 2.20 2.02% |
Performance4 of 100
| Odds Of DistressLess than 9
|
Ipsen SA is trading at 111.30 as of the 15th of November 2024, a 2.02% up since the beginning of the trading day. The stock's open price was 109.1. Ipsen SA has less than a 9 % chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Ipsen SA are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 16th of October 2024 and ending today, the 15th of November 2024. Click here to learn more.
Ipsen S.A. operates as a biopharmaceutical company worldwide. Ipsen S.A. was founded in 1929 and is headquartered in Boulogne-Billancourt, France. IPSEN operates under Drug ManufacturersSpecialty Generic classification in France and is traded on Paris Stock Exchange. The company has 82.63 M outstanding shares. More on Ipsen SA
Moving together with Ipsen Stock
Moving against Ipsen Stock
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Ipsen Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Ipsen SA's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Ipsen SA or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Richard Paulson |
| Business Concentration | Health Care, Pharmaceuticals, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Ipsen SA (IPN) is traded on Euronext Paris in France and employs 5,000 people. The company currently falls under 'Mid-Cap' category with a current market capitalization of 8.83 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Ipsen SA's market, we take the total number of its shares issued and multiply it by Ipsen SA's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Ipsen SA operates under Pharmaceuticals sector and is part of Health Care industry. The entity has 82.63 M outstanding shares.
Ipsen SA has accumulated about 1.17 B in cash with 971.4 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 8.9.
Check Ipsen SA Probability Of Bankruptcy
Ownership AllocationIpsen SA has a total of 82.63 Million outstanding shares. Ipsen SA secures significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Ipsen Ownership Details
Ipsen SA Risk Profiles
Although Ipsen SA's alpha and beta are two of the key measurements used to evaluate Ipsen SA's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 0.9819 | |||
| Semi Deviation | 1.12 | |||
| Standard Deviation | 1.28 | |||
| Variance | 1.63 |
Ipsen Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Ipsen SA without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
| All Next | Launch Module |
Ipsen SA Corporate Directors
| Henri Beaufour | Director | Profile | |
| Carol Xueref | Independent Director | Profile | |
| Margaret Liu | Independent Director | Profile | |
| Philippe Bonhomme | Director, Permanent representative of Beech Tree SA | Profile |
Other Information on Investing in Ipsen Stock
Ipsen SA financial ratios help investors to determine whether Ipsen Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Ipsen with respect to the benefits of owning Ipsen SA security.